C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/64 (2006.01) A61K 31/4164 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) C07D 233/54 (2006.01) C07D 233/56 (2006.01)
Patent
CA 2508335
The present invention relates to novel prodrugs of MPV-2426, to methods for preparing said prodrug forms, to pharmaceutical compositions containing such forms, and to methods for using the prodrug forms. A compound of general formula (I), or pharmaceutically acceptable salts hydrates thereof, wherein R represents unsubstituted or substituted lower alkyl, unsubstituted or substituted aryl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted lower alkylamino or a saturated five or six membered heterocyclic group containing one or two nitrogen atoms.(see formula I)
La présente invention concerne de nouveaux promédicaments de MPV-2426, des procédés pour produire ces formes de promédicaments, des compositions pharmaceutiques contenant de telles formes de promédicaments et des procédés pour utiliser lesdites formes de promédicaments.
Huuskonen Juhani
Jarvinen Tomi
Niemi Riku
Orion Corporation
Robic
LandOfFree
Imidazole derivatives having affinity for alpha 2 receptors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives having affinity for alpha 2 receptors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives having affinity for alpha 2 receptors... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2080049